Pacific Biosciences of California, Inc. (PACB)
2.09
-0.01
(-0.48%)
USD |
NASDAQ |
Oct 13, 13:16
Pacific Biosciences of California Free Cash Flow (Quarterly) : -39.19M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -39.19M |
| March 31, 2026 | -52.73M |
| December 31, 2025 | -19.93M |
| September 30, 2025 | -18.62M |
| June 30, 2025 | -29.93M |
| March 31, 2025 | -50.44M |
| December 31, 2024 | -32.27M |
| September 30, 2024 | -44.68M |
| June 30, 2024 | -55.74M |
| March 31, 2024 | -79.56M |
| December 31, 2023 | -59.63M |
| September 30, 2023 | -66.50M |
| June 30, 2023 | -50.84M |
| March 31, 2023 | -98.41M |
| December 31, 2022 | -65.65M |
| September 30, 2022 | -67.24M |
| June 30, 2022 | -64.58M |
| March 31, 2022 | -82.67M |
| December 31, 2021 | -34.55M |
| September 30, 2021 | -41.78M |
| June 30, 2021 | -17.28M |
| March 31, 2021 | -23.50M |
| December 31, 2020 | -14.33M |
| September 30, 2020 | -18.34M |
| June 30, 2020 | -24.11M |
| Date | Value |
|---|---|
| March 31, 2020 | 75.25M |
| December 31, 2019 | -18.32M |
| September 30, 2019 | -18.09M |
| June 30, 2019 | -18.17M |
| March 31, 2019 | -26.57M |
| December 31, 2018 | -19.04M |
| September 30, 2018 | -14.27M |
| June 30, 2018 | -15.85M |
| March 31, 2018 | -19.12M |
| December 31, 2017 | -21.26M |
| September 30, 2017 | -21.10M |
| June 30, 2017 | -16.26M |
| March 31, 2017 | -19.34M |
| December 31, 2016 | -15.55M |
| September 30, 2016 | -18.18M |
| June 30, 2016 | -21.68M |
| March 31, 2016 | -20.72M |
| December 31, 2015 | -1.592M |
| September 30, 2015 | -16.23M |
| June 30, 2015 | -8.449M |
| March 31, 2015 | -24.63M |
| December 31, 2014 | -15.83M |
| September 30, 2014 | -6.425M |
| June 30, 2014 | -14.08M |
| March 31, 2014 | -16.73M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Illumina, Inc. | 159.00M |
| Danaher Corp. | 1.265B |
| Thermo Fisher Scientific, Inc. | 1.675B |
| Agilent Technologies, Inc. | 439.00M |
| Bio-Rad Laboratories, Inc. | 66.70M |